ArticleScientific reports2017

Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

Eleni N Tsakiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.